Physician

Ali Imtiaz

According to 2025 Medicare claims, Ali Imtiaz (NPI: 1972036010) practices nephrology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60540-7430. Imtiaz is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Imtiaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 2,992 HCPCS/CPT codes, and received $159,311 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 380 prescription claims across 117 beneficiaries totaling $41,708 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 12 records totaling $268. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,482 to $41,708. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$80K$159K2022 Medicare payment: $15,787 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $109,617 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $159,311 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202275183$15,787
20232741,639$109,617
20243632,992$159,311

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$42K2018 Drug cost: $5,482 (USD; Tot_Drug_Cst)2019 Drug cost: $6,710 (USD; Tot_Drug_Cst)2020 Drug cost: $8,721 (USD; Tot_Drug_Cst)2021 Drug cost: $2,356 (USD; Tot_Drug_Cst)2022 Drug cost: $10,986 (USD; Tot_Drug_Cst)2023 Drug cost: $28,025 (USD; Tot_Drug_Cst)2024 Drug cost: $41,708 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201855117$5,482
201958136$6,710
20202666$8,721
20211941$2,356
202228105$10,986
202382228$28,025
2024117380$41,708

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes176614$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more131228$95
36415Insertion of needle into vein for collection of blood sample139294$9
80069Kidney function blood test panel147328$8
82570Creatinine level to test for kidney function or muscle injury116323$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin14870$16,851
FarxigaDapagliflozin Propanediol11840$14,940
Nifedipine ErNifedipine322,820$1,143
Losartan PotassiumLosartan Potassium564,905$623
Hydralazine HclHydralazine Hcl262,025$479

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$268Vifor Pharma, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali Imtiaz?

Tedicare shows public-source Medicare data for Ali Imtiaz (NPI 1972036010), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Imtiaz have ACO affiliation data?

Ali Imtiaz is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Ali Imtiaz?

Ali Imtiaz is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Ali Imtiaz have Open Payments data?

Ali Imtiaz has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.